Cervus elaphus chromosome 32, mCerEla1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Cervidae; Cervinae; Cervus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU343109.1.\nAssembly name: mCerEla1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/07/07. The original whole-genome shotgun project has the\naccession CAJVBL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Cervus elaphus Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
opioid-binding protein/cell adhesion molecule-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
ankyrin repeat domain-containing protein 26-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122688040, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122688040, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mitochondrial import receptor subunit TOM20 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 22 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 27 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122688033, transcript variant X1
uncharacterized LOC122688033, transcript variant X3
uncharacterized LOC122688033, transcript variant X2
CLN8 transmembrane ER and ERGIC protein, transcript variant X4
CLN8 transmembrane ER and ERGIC protein, transcript variant X2
CLN8 transmembrane ER and ERGIC protein, transcript variant X3
CLN8 transmembrane ER and ERGIC protein, transcript variant X1
CLN8 transmembrane ER and ERGIC protein, transcript variant X7
CLN8 transmembrane ER and ERGIC protein, transcript variant X6
CLN8 transmembrane ER and ERGIC protein, transcript variant X5
serine/arginine repetitive matrix protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122687960, transcript variant X2
uncharacterized LOC122687960, transcript variant X1
uncharacterized LOC122687784, transcript variant X1
uncharacterized LOC122687784, transcript variant X2
Rho guanine nucleotide exchange factor 10, transcript variant X1
Rho guanine nucleotide exchange factor 10, transcript variant X4
Rho guanine nucleotide exchange factor 10, transcript variant X2
Rho guanine nucleotide exchange factor 10, transcript variant X3
rho guanine nucleotide exchange factor 10 isoform X1
rho guanine nucleotide exchange factor 10 isoform X4
rho guanine nucleotide exchange factor 10 isoform X2
rho guanine nucleotide exchange factor 10 isoform X3
kelch repeat and BTB domain containing 11, transcript variant X5
kelch repeat and BTB domain containing 11, transcript variant X1
kelch repeat and BTB domain containing 11, transcript variant X7
kelch repeat and BTB domain containing 11, transcript variant X3
kelch repeat and BTB domain containing 11, transcript variant X8
kelch repeat and BTB domain containing 11, transcript variant X2
kelch repeat and BTB domain containing 11, transcript variant X4
kelch repeat and BTB domain containing 11, transcript variant X6
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon GCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
kelch repeat and BTB domain-containing protein 11
CUB and sushi domain-containing protein 1
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
1-acylglycerol-3-phosphate O-acyltransferase 5
1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 5 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 45% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative beta-defensin 109B
zinc finger protein 596-like, transcript variant X6
zinc finger protein 596-like, transcript variant X10
zinc finger protein 596-like, transcript variant X15
zinc finger protein 596-like, transcript variant X2
zinc finger protein 596-like, transcript variant X16
zinc finger protein 596-like, transcript variant X12
zinc finger protein 596-like, transcript variant X1
zinc finger protein 596-like, transcript variant X14
zinc finger protein 596-like, transcript variant X13
zinc finger protein 596-like, transcript variant X11
zinc finger protein 596-like, transcript variant X5
zinc finger protein 596-like, transcript variant X17
zinc finger protein 596-like, transcript variant X7
zinc finger protein 596-like, transcript variant X4
zinc finger protein 596-like, transcript variant X18
zinc finger protein 596-like, transcript variant X8
zinc finger protein 596-like, transcript variant X3
zinc finger protein 596-like, transcript variant X9
zinc finger protein 705A-like isoform X1
zinc finger protein 705A-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins
beta-defensin 103A-like, transcript variant X2
beta-defensin 103A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
neuronal membrane glycoprotein M6-a isoform X2
neuronal membrane glycoprotein M6-a isoform X1
neuronal membrane glycoprotein M6-a isoform X3
WD repeat domain 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat domain 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
WD repeat domain 17, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat domain 17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat-containing protein 17 isoform X1
WD repeat-containing protein 17 isoform X2
WD repeat-containing protein 17 isoform X3
spermatogenesis associated 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 44 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
spermatogenesis associated 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 44 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
spermatogenesis-associated protein 4 isoform X1
spermatogenesis-associated protein 4 isoform X2
ankyrin repeat and SOCS box containing 5, transcript variant X1
ankyrin repeat and SOCS box containing 5, transcript variant X2
ankyrin repeat and SOCS box containing 5, transcript variant X3
ankyrin repeat and SOCS box protein 5 isoform X1
ankyrin repeat and SOCS box protein 5 isoform X2
ankyrin repeat and SOCS box protein 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC122687924, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122687924, transcript variant X3
uncharacterized LOC122687924, transcript variant X4
uncharacterized LOC122687924, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00099
teneurin transmembrane protein 3, transcript variant X1
teneurin transmembrane protein 3, transcript variant X3
teneurin transmembrane protein 3, transcript variant X5
teneurin transmembrane protein 3, transcript variant X6
teneurin transmembrane protein 3, transcript variant X4
teneurin transmembrane protein 3, transcript variant X7
teneurin transmembrane protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WW and C2 domain containing 2, transcript variant X1
WW and C2 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
CDKN2A interacting protein, transcript variant X2
CDKN2A interacting protein, transcript variant X1
uncharacterized LOC122687890, transcript variant X3
uncharacterized LOC122687890, transcript variant X2
uncharacterized LOC122687890, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RWD domain containing 4, transcript variant X1
RWD domain containing 4, transcript variant X2
RWD domain-containing protein 4 isoform X1
RWD domain-containing protein 4 isoform X2
trafficking protein particle complex subunit 11, transcript variant X2
trafficking protein particle complex subunit 11, transcript variant X1
trafficking protein particle complex subunit 11, transcript variant X3
trafficking protein particle complex subunit 11, transcript variant X5
trafficking protein particle complex subunit 11 isoform X1
trafficking protein particle complex subunit 11 isoform X2
trafficking protein particle complex subunit 11, transcript variant X4
trafficking protein particle complex subunit 11 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ectonucleotide pyrophosphatase/phosphodiesterase 6
glycerophosphocholine cholinephosphodiesterase ENPP6
interferon regulatory factor 2, transcript variant X1
interferon regulatory factor 2, transcript variant X2
interferon regulatory factor 2, transcript variant X3
interferon regulatory factor 2, transcript variant X4
primase and DNA directed polymerase, transcript variant X1
primase and DNA directed polymerase, transcript variant X3
primase and DNA directed polymerase, transcript variant X4
primase and DNA directed polymerase, transcript variant X2
primase and DNA directed polymerase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA-directed primase/polymerase protein isoform X1
DNA-directed primase/polymerase protein isoform X2
DNA-directed primase/polymerase protein isoform X3
DNA-directed primase/polymerase protein isoform X4
primase and DNA directed polymerase, transcript variant X6
DNA-directed primase/polymerase protein isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
acyl-CoA synthetase long chain family member 1, transcript variant X2
acyl-CoA synthetase long chain family member 1, transcript variant X1
acyl-CoA synthetase long chain family member 1, transcript variant X5
acyl-CoA synthetase long chain family member 1, transcript variant X4
acyl-CoA synthetase long chain family member 1, transcript variant X3
acyl-CoA synthetase long chain family member 1, transcript variant X6
long-chain-fatty-acid--CoA ligase 1 isoform X2
long-chain-fatty-acid--CoA ligase 1 isoform X1
helt bHLH transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
helt bHLH transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
hairy and enhancer of split-related protein HELT isoform X1
hairy and enhancer of split-related protein HELT isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
cilia and flagella associated protein 97, transcript variant X3
cilia and flagella associated protein 97, transcript variant X1
cilia and flagella associated protein 97, transcript variant X2
cilia- and flagella-associated protein 97 isoform X2
cilia- and flagella-associated protein 97 isoform X1
LRP2 binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LRP2 binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LRP2 binding protein, transcript variant X3
ankyrin repeat domain 37, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ankyrin repeat domain 37, transcript variant X2
ankyrin repeat domain-containing protein 37 isoform X1
ankyrin repeat domain-containing protein 37 isoform X2
UFM1 specific peptidase 2, transcript variant X2
UFM1 specific peptidase 2, transcript variant X3
UFM1 specific peptidase 2, transcript variant X1
chromosome 32 C4orf47 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
chromosome 32 C4orf47 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
chromosome 32 C4orf47 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
chromosome 32 C4orf47 homolog, transcript variant X4
chromosome 32 C4orf47 homolog, transcript variant X2
chromosome 32 C4orf47 homolog, transcript variant X1
UPF0602 protein C4orf47 homolog isoform X2
UPF0602 protein C4orf47 homolog isoform X3
UPF0602 protein C4orf47 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 10% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 110
PDZ and LIM domain 3, transcript variant X2
PDZ and LIM domain 3, transcript variant X3
PDZ and LIM domain 3, transcript variant X1
sorbin and SH3 domain containing 2, transcript variant X17
sorbin and SH3 domain containing 2, transcript variant X15
sorbin and SH3 domain containing 2, transcript variant X13
sorbin and SH3 domain containing 2, transcript variant X14
sorbin and SH3 domain containing 2, transcript variant X16
sorbin and SH3 domain-containing protein 2 isoform X13
sorbin and SH3 domain-containing protein 2 isoform X14
sorbin and SH3 domain-containing protein 2 isoform X12
sorbin and SH3 domain-containing protein 2 isoform X16
sorbin and SH3 domain-containing protein 2 isoform X15
sorbin and SH3 domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain containing 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain containing 2, transcript variant X1
sorbin and SH3 domain containing 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain containing 2, transcript variant X8
sorbin and SH3 domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain containing 2, transcript variant X9
sorbin and SH3 domain containing 2, transcript variant X11
sorbin and SH3 domain containing 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain-containing protein 2 isoform X9
sorbin and SH3 domain-containing protein 2 isoform X4
sorbin and SH3 domain-containing protein 2 isoform X2
sorbin and SH3 domain-containing protein 2 isoform X8
sorbin and SH3 domain-containing protein 2 isoform X7
sorbin and SH3 domain-containing protein 2 isoform X5
sorbin and SH3 domain-containing protein 2 isoform X3
sorbin and SH3 domain-containing protein 2 isoform X1
sorbin and SH3 domain-containing protein 2 isoform X11
sorbin and SH3 domain-containing protein 2 isoform X10
sorbin and SH3 domain containing 2, transcript variant X7
sorbin and SH3 domain-containing protein 2 isoform X6
toll like receptor 3, transcript variant X3
toll like receptor 3, transcript variant X5
toll like receptor 3, transcript variant X1
toll like receptor 3, transcript variant X2
toll like receptor 3, transcript variant X4
family with sequence similarity 149 member A, transcript variant X1
family with sequence similarity 149 member A, transcript variant X2
family with sequence similarity 149 member A, transcript variant X5
family with sequence similarity 149 member A, transcript variant X4
family with sequence similarity 149 member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 15 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
FAT atypical cadherin 1, transcript variant X5
FAT atypical cadherin 1, transcript variant X2
FAT atypical cadherin 1, transcript variant X4
FAT atypical cadherin 1, transcript variant X1
FAT atypical cadherin 1, transcript variant X3
FAT atypical cadherin 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
10 kDa heat shock protein, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122688014, transcript variant X1
uncharacterized LOC122688014, transcript variant X3
uncharacterized LOC122688014, transcript variant X2
uncharacterized LOC122688014, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable E3 ubiquitin-protein ligase TRIML2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
probable E3 ubiquitin-protein ligase TRIML1
COORDINATES: nucleotide motif:Rfam:12.0:RF01241
COORDINATES: nucleotide motif:Rfam:12.0:RF00494
COORDINATES: nucleotide motif:Rfam:12.0:RF00493
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
pericentriolar material 1, transcript variant X12
pericentriolar material 1, transcript variant X11
pericentriolar material 1, transcript variant X4
pericentriolar material 1, transcript variant X10
pericentriolar material 1, transcript variant X7
pericentriolar material 1, transcript variant X3
pericentriolar material 1, transcript variant X9
pericentriolar material 1, transcript variant X6
pericentriolar material 1, transcript variant X8
pericentriolar material 1, transcript variant X5
pericentriolar material 1, transcript variant X1
pericentriolar material 1, transcript variant X2
pericentriolar material 1, transcript variant X15
pericentriolar material 1, transcript variant X14
pericentriolar material 1, transcript variant X13
pericentriolar material 1, transcript variant X16
pericentriolar material 1 protein isoform X14
pericentriolar material 1 protein isoform X13
pericentriolar material 1 protein isoform X11
pericentriolar material 1 protein isoform X12
pericentriolar material 1 protein isoform X15
pericentriolar material 1 protein isoform X10
pericentriolar material 1 protein isoform X3
pericentriolar material 1 protein isoform X9
pericentriolar material 1 protein isoform X6
pericentriolar material 1 protein isoform X2
pericentriolar material 1 protein isoform X8
pericentriolar material 1 protein isoform X5
pericentriolar material 1 protein isoform X7
pericentriolar material 1 protein isoform X4
pericentriolar material 1 protein isoform X1
pericentriolar material 1, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
pericentriolar material 1 protein isoform X16
microtubule associated scaffold protein 1, transcript variant X2
microtubule associated scaffold protein 1, transcript variant X1
microtubule associated scaffold protein 1, transcript variant X3
microtubule-associated tumor suppressor 1 isoform X1
microtubule-associated tumor suppressor 1 isoform X2
microtubule associated scaffold protein 1, transcript variant X5
microtubule-associated tumor suppressor 1 isoform X4
microtubule associated scaffold protein 1, transcript variant X4
microtubule-associated tumor suppressor 1 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
microtubule associated scaffold protein 1, transcript variant X6
microtubule-associated tumor suppressor 1 isoform X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
platelet derived growth factor receptor like
platelet-derived growth factor receptor-like protein
solute carrier family 7 member 2, transcript variant X3
solute carrier family 7 member 2, transcript variant X1
solute carrier family 7 member 2, transcript variant X4
solute carrier family 7 member 2, transcript variant X2
cationic amino acid transporter 2 isoform X2
cationic amino acid transporter 2 isoform X1
cationic amino acid transporter 2 isoform X3
vacuolar protein sorting-associated protein 37A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
CCR4-NOT transcription complex subunit 7, transcript variant X1
CCR4-NOT transcription complex subunit 7, transcript variant X2
CCR4-NOT transcription complex subunit 7 isoform X1
CCR4-NOT transcription complex subunit 7 isoform X2
zinc finger DHHC-type palmitoyltransferase 2
mitochondrial calcium uptake family member 3, transcript variant X3
mitochondrial calcium uptake family member 3, transcript variant X1
mitochondrial calcium uptake family member 3, transcript variant X2
calcium uptake protein 3, mitochondrial isoform X3
calcium uptake protein 3, mitochondrial isoform X2
calcium uptake protein 3, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 4 ESTs, 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
macrophage scavenger receptor 1, transcript variant X1
macrophage scavenger receptor 1, transcript variant X2
macrophage scavenger receptor types I and II isoform X1
macrophage scavenger receptor types I and II isoform X2
tumor suppressor candidate 3, transcript variant X3
tumor suppressor candidate 3, transcript variant X1
tumor suppressor candidate 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00438
uncharacterized LOC122688123, transcript variant X1
uncharacterized LOC122688123, transcript variant X2
uncharacterized LOC122688123, transcript variant X3
uncharacterized LOC122688123, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DLC1 Rho GTPase activating protein, transcript variant X2
DLC1 Rho GTPase activating protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DLC1 Rho GTPase activating protein, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DLC1 Rho GTPase activating protein, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DLC1 Rho GTPase activating protein, transcript variant X1
DLC1 Rho GTPase activating protein, transcript variant X4
DLC1 Rho GTPase activating protein, transcript variant X3
rho GTPase-activating protein 7 isoform X1
rho GTPase-activating protein 7 isoform X2
rho GTPase-activating protein 7 isoform X6
rho GTPase-activating protein 7 isoform X7
DLC1 Rho GTPase activating protein, transcript variant X5
rho GTPase-activating protein 7 isoform X3
DLC1 Rho GTPase activating protein, transcript variant X6
rho GTPase-activating protein 7 isoform X4
DLC1 Rho GTPase activating protein, transcript variant X9
DLC1 Rho GTPase activating protein, transcript variant X7
DLC1 Rho GTPase activating protein, transcript variant X8
rho GTPase-activating protein 7 isoform X5
tRNA methyltransferase 9B (putative), transcript variant X4
tRNA methyltransferase 9B (putative), transcript variant X3
tRNA methyltransferase 9B (putative), transcript variant X2
tRNA methyltransferase 9B (putative), transcript variant X7
tRNA methyltransferase 9B (putative), transcript variant X1
tRNA methyltransferase 9B (putative), transcript variant X6
tRNA methyltransferase 9B (putative), transcript variant X5
probable tRNA methyltransferase 9B isoform X1
probable tRNA methyltransferase 9B isoform X2
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LON peptidase N-terminal domain and ring finger 1
LON peptidase N-terminal domain and RING finger protein 1
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X1
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X3
PEAK1 related, kinase-activating pseudokinase 1, transcript variant X2
uncharacterized LOC122688096, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122688096, transcript variant X2
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
low-density lipoprotein receptor-related protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multifunctional ROCO family signaling regulator 1, transcript variant X1
multifunctional ROCO family signaling regulator 1, transcript variant X2
malignant fibrous histiocytoma-amplified sequence 1 isoform X1
malignant fibrous histiocytoma-amplified sequence 1 isoform X2
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
COORDINATES: nucleotide motif:Rfam:12.0:RF00408
exoribonuclease 1, transcript variant X1
exoribonuclease 1, transcript variant X3
exoribonuclease 1, transcript variant X2
protein phosphatase 1 regulatory subunit 3B, transcript variant X1
protein phosphatase 1 regulatory subunit 3B, transcript variant X2
protein phosphatase 1 regulatory subunit 3B isoform X1
protein phosphatase 1 regulatory subunit 3B isoform X2
poly [ADP-ribose] polymerase tankyrase-1
ubiquitin carboxyl-terminal hydrolase 11-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 9 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquitin carboxyl-terminal hydrolase 11-like
store-operated calcium entry associated regulatory factor
store-operated calcium entry-associated regulatory factor
leptin receptor overlapping transcript like 1
leptin receptor overlapping transcript-like 1
membrane bound O-acyltransferase domain containing 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RNA binding protein, mRNA processing factor, transcript variant X1
RNA binding protein, mRNA processing factor, transcript variant X3
RNA binding protein, mRNA processing factor, transcript variant X2
RNA-binding protein with multiple splicing isoform X1
RNA-binding protein with multiple splicing isoform X3
RNA-binding protein with multiple splicing isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00568
general transcription factor IIE subunit 2
transcription initiation factor IIE subunit beta
small integral membrane protein 18, transcript variant X1
small integral membrane protein 18, transcript variant X2
small integral membrane protein 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: signal recognition particle receptor subunit beta
protein phosphatase 2 catalytic subunit beta, transcript variant X2
protein phosphatase 2 catalytic subunit beta, transcript variant X1
serine/threonine-protein phosphatase 2A catalytic subunit beta isoform isoform X2
serine/threonine-protein phosphatase 2A catalytic subunit beta isoform isoform X1
testis expressed 15, meiosis and synapsis associated
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
10 kDa heat shock protein, mitochondrial-like
purine rich element binding protein G, transcript variant X3
purine rich element binding protein G, transcript variant X2
purine-rich element-binding protein gamma isoform X3
purine-rich element-binding protein gamma isoform X2
purine rich element binding protein G, transcript variant X4
purine-rich element-binding protein gamma isoform X4
purine rich element binding protein G, transcript variant X1
purine-rich element-binding protein gamma isoform X1
WRN RecQ like helicase, transcript variant X5
WRN RecQ like helicase, transcript variant X1
WRN RecQ like helicase, transcript variant X6
WRN RecQ like helicase, transcript variant X2
WRN RecQ like helicase, transcript variant X4
WRN RecQ like helicase, transcript variant X3
Werner syndrome ATP-dependent helicase isoform X3
small nuclear ribonucleoprotein Sm D1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Werner syndrome ATP-dependent helicase isoform X1
Werner syndrome ATP-dependent helicase isoform X2
Werner syndrome ATP-dependent helicase isoform X4
Werner syndrome ATP-dependent helicase isoform X5
WRN RecQ like helicase, transcript variant X7
WRN RecQ like helicase, transcript variant X8
WRN RecQ like helicase, transcript variant X9
Werner syndrome ATP-dependent helicase isoform X6
Werner syndrome ATP-dependent helicase isoform X7
Werner syndrome ATP-dependent helicase isoform X8
WRN RecQ like helicase, transcript variant X10
Werner syndrome ATP-dependent helicase isoform X9
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pro-neuregulin-1, membrane-bound isoform isoform X5
pro-neuregulin-1, membrane-bound isoform isoform X4
pro-neuregulin-1, membrane-bound isoform isoform X6
pro-neuregulin-1, membrane-bound isoform isoform X7
pro-neuregulin-1, membrane-bound isoform isoform X10
pro-neuregulin-1, membrane-bound isoform isoform X11
pro-neuregulin-1, membrane-bound isoform isoform X2
pro-neuregulin-1, membrane-bound isoform isoform X1
pro-neuregulin-1, membrane-bound isoform isoform X3
pro-neuregulin-1, membrane-bound isoform isoform X9
pro-neuregulin-1, membrane-bound isoform isoform X8
pro-neuregulin-1, membrane-bound isoform isoform X12
pro-neuregulin-1, membrane-bound isoform isoform X13
TELO2 interacting protein 2, transcript variant X2
TELO2 interacting protein 2, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
ring finger protein 122, transcript variant X2
ring finger protein 122, transcript variant X1
3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7-like, transcript variant X1
3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7-like, transcript variant X2
3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7-like isoform X1
3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00432
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
unc-5 netrin receptor D, transcript variant X1
unc-5 netrin receptor D, transcript variant X3
unc-5 netrin receptor D, transcript variant X2
unc-5 netrin receptor D, transcript variant X4
uncharacterized LOC122688125, transcript variant X2
uncharacterized LOC122688125, transcript variant X1
potassium calcium-activated channel subfamily U member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122687881, transcript variant X2
uncharacterized LOC122687881, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
ER lipid raft associated 2, transcript variant X2
ER lipid raft associated 2, transcript variant X4
ER lipid raft associated 2, transcript variant X1
ER lipid raft associated 2, transcript variant X3
pyridoxal phosphate binding protein, transcript variant X1
pyridoxal phosphate binding protein, transcript variant X2
pyridoxal phosphate homeostasis protein isoform X1
pyridoxal phosphate homeostasis protein isoform X2
BRF2 RNA polymerase III transcription initiation factor subunit
transcription factor IIIB 50 kDa subunit
RAB11 family interacting protein 1, transcript variant X1
RAB11 family interacting protein 1, transcript variant X2
rab11 family-interacting protein 1 isoform X2
rab11 family-interacting protein 1 isoform X1
glutamic-oxaloacetic transaminase 1 like 1
putative aspartate aminotransferase, cytoplasmic 2
adrenoceptor beta 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 4 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adrenoceptor beta 3, transcript variant X2
adrenoceptor beta 3, transcript variant X3
adrenoceptor beta 3, transcript variant X4
adrenoceptor beta 3, transcript variant X6
adrenoceptor beta 3, transcript variant X5
eukaryotic translation initiation factor 4E binding protein 1
eukaryotic translation initiation factor 4E-binding protein 1
ASH2 like, histone lysine methyltransferase complex subunit
set1/Ash2 histone methyltransferase complex subunit ASH2
steroidogenic acute regulatory protein, mitochondrial
LSM1 homolog, mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm1
BAG family molecular chaperone regulator 4
DDHD domain containing 2, transcript variant X2
DDHD domain containing 2, transcript variant X3
DDHD domain containing 2, transcript variant X4
DDHD domain containing 2, transcript variant X1
DDHD domain containing 2, transcript variant X5
phospholipid phosphatase 5, transcript variant X3
phospholipid phosphatase 5, transcript variant X7
phospholipid phosphatase 5, transcript variant X6
phospholipid phosphatase 5, transcript variant X2
phospholipid phosphatase 5, transcript variant X1
phospholipid phosphatase 5, transcript variant X4
phospholipid phosphatase 5, transcript variant X10
phospholipid phosphatase 5, transcript variant X5
phospholipid phosphatase 5, transcript variant X9
phospholipid phosphatase 5, transcript variant X11
phospholipid phosphatase 5, transcript variant X12
phospholipid phosphatase 5, transcript variant X8
phospholipid phosphatase 5, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
nuclear receptor binding SET domain protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 43 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nuclear receptor binding SET domain protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 43 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear receptor binding SET domain protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 43 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
nuclear receptor binding SET domain protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 40 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
nuclear receptor binding SET domain protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 mRNAs, 43 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
histone-lysine N-methyltransferase NSD3 isoform X3
histone-lysine N-methyltransferase NSD3 isoform X2
histone-lysine N-methyltransferase NSD3 isoform X1
nuclear receptor binding SET domain protein 3, transcript variant X6
histone-lysine N-methyltransferase NSD3 isoform X4
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X4
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X5
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LETM1 domain-containing protein LETM2, mitochondrial isoform X1
LETM1 domain-containing protein LETM2, mitochondrial isoform X2
leucine zipper and EF-hand containing transmembrane protein 2, transcript variant X8
LETM1 domain-containing protein LETM2, mitochondrial isoform X3
fibroblast growth factor receptor 1, transcript variant X6
fibroblast growth factor receptor 1, transcript variant X5
fibroblast growth factor receptor 1, transcript variant X2
fibroblast growth factor receptor 1, transcript variant X4
fibroblast growth factor receptor 1, transcript variant X10
fibroblast growth factor receptor 1, transcript variant X8
fibroblast growth factor receptor 1, transcript variant X3
fibroblast growth factor receptor 1, transcript variant X1
fibroblast growth factor receptor 1, transcript variant X9
fibroblast growth factor receptor 1, transcript variant X7
fibroblast growth factor receptor 1 isoform X8
fibroblast growth factor receptor 1 isoform X7
fibroblast growth factor receptor 1 isoform X6
fibroblast growth factor receptor 1 isoform X5
fibroblast growth factor receptor 1 isoform X4
fibroblast growth factor receptor 1 isoform X3
fibroblast growth factor receptor 1 isoform X2
fibroblast growth factor receptor 1 isoform X1
cytochrome c oxidase subunit NDUFA4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122688005, transcript variant X2
uncharacterized LOC122688005, transcript variant X1
uncharacterized LOC122687992, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122687992, transcript variant X3
uncharacterized LOC122687992, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transforming acidic coiled-coil containing protein 1, transcript variant X10
transforming acidic coiled-coil containing protein 1, transcript variant X7
transforming acidic coiled-coil-containing protein 1 isoform X7
transforming acidic coiled-coil containing protein 1, transcript variant X8
transforming acidic coiled-coil containing protein 1, transcript variant X3
transforming acidic coiled-coil containing protein 1, transcript variant X5
transforming acidic coiled-coil containing protein 1, transcript variant X9
transforming acidic coiled-coil containing protein 1, transcript variant X13
transforming acidic coiled-coil-containing protein 1 isoform X3
transforming acidic coiled-coil-containing protein 1 isoform X5
transforming acidic coiled-coil-containing protein 1 isoform X9
transforming acidic coiled-coil-containing protein 1 isoform X12
transforming acidic coiled-coil containing protein 1, transcript variant X1
transforming acidic coiled-coil containing protein 1, transcript variant X4
transforming acidic coiled-coil containing protein 1, transcript variant X2
transforming acidic coiled-coil containing protein 1, transcript variant X6
transforming acidic coiled-coil containing protein 1, transcript variant X11
transforming acidic coiled-coil containing protein 1, transcript variant X12
transforming acidic coiled-coil-containing protein 1 isoform X1
transforming acidic coiled-coil-containing protein 1 isoform X4
transforming acidic coiled-coil-containing protein 1 isoform X2
transforming acidic coiled-coil-containing protein 1 isoform X6
transforming acidic coiled-coil-containing protein 1 isoform X10
transforming acidic coiled-coil-containing protein 1 isoform X11
transforming acidic coiled-coil-containing protein 1 isoform X8
pleckstrin homology domain containing A2, transcript variant X1
pleckstrin homology domain containing A2, transcript variant X2
pleckstrin homology domain containing A2, transcript variant X3
pleckstrin homology domain-containing family A member 2
ADAM metallopeptidase domain 9, transcript variant X1
disintegrin and metalloproteinase domain-containing protein 9 isoform X1
ADAM metallopeptidase domain 9, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 9 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 2
A disintegrin and metallopeptidase domain 3-like, transcript variant X4
A disintegrin and metallopeptidase domain 3-like, transcript variant X3
A disintegrin and metallopeptidase domain 3-like, transcript variant X1
A disintegrin and metallopeptidase domain 3-like, transcript variant X2
A disintegrin and metallopeptidase domain 3-like isoform X4
A disintegrin and metallopeptidase domain 3-like isoform X3
A disintegrin and metallopeptidase domain 3-like isoform X2
A disintegrin and metallopeptidase domain 3-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 18
coiled-coil domain-containing protein 43
indoleamine 2,3-dioxygenase 2, transcript variant X2
indoleamine 2,3-dioxygenase 2, transcript variant X4
indoleamine 2,3-dioxygenase 2, transcript variant X3
indoleamine 2,3-dioxygenase 2, transcript variant X5
indoleamine 2,3-dioxygenase 2, transcript variant X1
indoleamine 2,3-dioxygenase 2 isoform X1
indoleamine 2,3-dioxygenase 2 isoform X2
indoleamine 2,3-dioxygenase 2 isoform X4
indoleamine 2,3-dioxygenase 2 isoform X3
indoleamine 2,3-dioxygenase 2 isoform X5
transcriptional and immune response regulator
zinc finger matrin-type 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 6 ESTs, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger matrin-type 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger matrin-type 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger matrin-type protein 4 isoform X1
zinc finger matrin-type protein 4 isoform X2
zinc finger matrin-type protein 4 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
DNA replication complex GINS protein SLD5
glycerol-3-phosphate acyltransferase 4, transcript variant X1
glycerol-3-phosphate acyltransferase 4, transcript variant X2
glycerol-3-phosphate acyltransferase 4 isoform X1
glycerol-3-phosphate acyltransferase 4, transcript variant X3
glycerol-3-phosphate acyltransferase 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysine acetyltransferase 6A, transcript variant X2
lysine acetyltransferase 6A, transcript variant X1
histone acetyltransferase KAT6A isoform X2
histone acetyltransferase KAT6A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adaptor related protein complex 3 subunit mu 2, transcript variant X1
adaptor related protein complex 3 subunit mu 2, transcript variant X3
adaptor related protein complex 3 subunit mu 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X2
inhibitor of nuclear factor kappa B kinase subunit beta, transcript variant X1
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2
inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
uncharacterized LOC122687690, transcript variant X2
uncharacterized LOC122687690, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC122687690 isoform X2
uncharacterized protein LOC122687690 isoform X1
DNA polymerase beta, transcript variant X2
DNA polymerase beta, transcript variant X1
DNA polymerase beta, transcript variant X3
dickkopf WNT signaling pathway inhibitor 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase A-like
voltage dependent anion channel 3, transcript variant X1
voltage dependent anion channel 3, transcript variant X3
voltage dependent anion channel 3, transcript variant X4
voltage dependent anion channel 3, transcript variant X2
voltage-dependent anion-selective channel protein 3 isoform X1
voltage-dependent anion-selective channel protein 3 isoform X2
solute carrier family 20 member 2, transcript variant X3
solute carrier family 20 member 2, transcript variant X2
solute carrier family 20 member 2, transcript variant X1
sodium-dependent phosphate transporter 2
small integral membrane protein 19, transcript variant X2
small integral membrane protein 19, transcript variant X1
small integral membrane protein 19 isoform X1
small integral membrane protein 19 isoform X2
cholinergic receptor nicotinic beta 3 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuronal acetylcholine receptor subunit beta-3
cholinergic receptor nicotinic alpha 6 subunit
neuronal acetylcholine receptor subunit alpha-6
ring finger protein 170, transcript variant X2
ring finger protein 170, transcript variant X1
ring finger protein 170, transcript variant X3
ring finger protein 170, transcript variant X4
E3 ubiquitin-protein ligase RNF170 isoform X2
E3 ubiquitin-protein ligase RNF170 isoform X1
E3 ubiquitin-protein ligase RNF170 isoform X3
hook microtubule tethering protein 3, transcript variant X4
hook microtubule tethering protein 3, transcript variant X5
hook microtubule tethering protein 3, transcript variant X3
hook microtubule tethering protein 3, transcript variant X1
hook microtubule tethering protein 3, transcript variant X2
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
protein O-mannose kinase, transcript variant X7
protein O-mannose kinase, transcript variant X4
protein O-mannose kinase, transcript variant X11
protein O-mannose kinase, transcript variant X1
protein O-mannose kinase, transcript variant X8
protein O-mannose kinase, transcript variant X10
protein O-mannose kinase, transcript variant X14
protein O-mannose kinase, transcript variant X12
protein O-mannose kinase, transcript variant X13
protein O-mannose kinase, transcript variant X2
protein O-mannose kinase, transcript variant X6
protein O-mannose kinase, transcript variant X3
protein O-mannose kinase, transcript variant X15
protein O-mannose kinase, transcript variant X5
protein O-mannose kinase, transcript variant X9
heparan-alpha-glucosaminide N-acetyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 42 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
integrator complex subunit 10, transcript variant X1
integrator complex subunit 10, transcript variant X2
integrator complex subunit 10, transcript variant X3
integrator complex subunit 10 isoform X2
integrator complex subunit 10 isoform X1
integrator complex subunit 10 isoform X3
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X6
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X17
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X12
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X4
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X15
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X10
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X2
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X9
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X14
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X8
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X5
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X16
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X13
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X19
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X7
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X1
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X11
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X3
chondroitin sulfate N-acetylgalactosaminyltransferase 1, transcript variant X18
chondroitin sulfate N-acetylgalactosaminyltransferase 1 isoform X1
chondroitin sulfate N-acetylgalactosaminyltransferase 1 isoform X2
chondroitin sulfate N-acetylgalactosaminyltransferase 1 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
SH2 domain containing 4A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SH2 domain containing 4A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SH2 domain containing 4A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SH2 domain-containing protein 4A isoform X2
SH2 domain-containing protein 4A isoform X1
pleckstrin and Sec7 domain containing 3, transcript variant X1
pleckstrin and Sec7 domain containing 3, transcript variant X7
pleckstrin and Sec7 domain containing 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PH and SEC7 domain-containing protein 3 isoform X1
PH and SEC7 domain-containing protein 3 isoform X4
PH and SEC7 domain-containing protein 3 isoform X5
pleckstrin and Sec7 domain containing 3, transcript variant X3
pleckstrin and Sec7 domain containing 3, transcript variant X6
pleckstrin and Sec7 domain containing 3, transcript variant X2
PH and SEC7 domain-containing protein 3 isoform X2
pleckstrin and Sec7 domain containing 3, transcript variant X5
pleckstrin and Sec7 domain containing 3, transcript variant X4
PH and SEC7 domain-containing protein 3 isoform X3
pleckstrin and Sec7 domain containing 3, transcript variant X9
pleckstrin and Sec7 domain containing 3, transcript variant X11
PH and SEC7 domain-containing protein 3 isoform X8
PH and SEC7 domain-containing protein 3 isoform X6
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pleckstrin and Sec7 domain containing 3, transcript variant X12
pleckstrin and Sec7 domain containing 3, transcript variant X10
PH and SEC7 domain-containing protein 3 isoform X7
PH and SEC7 domain-containing protein 3 isoform X9
pleckstrin and Sec7 domain containing 3, transcript variant X13
pleckstrin and Sec7 domain containing 3, transcript variant X14
PH and SEC7 domain-containing protein 3 isoform X11
PH and SEC7 domain-containing protein 3 isoform X10
arylamine N-acetyltransferase 1, transcript variant X2
arylamine N-acetyltransferase 1, transcript variant X1
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
leucine rich repeat containing 3B, transcript variant X8
leucine rich repeat containing 3B, transcript variant X1
leucine rich repeat containing 3B, transcript variant X2
leucine rich repeat containing 3B, transcript variant X4
leucine rich repeat containing 3B, transcript variant X6
leucine rich repeat containing 3B, transcript variant X7
leucine rich repeat containing 3B, transcript variant X3
leucine rich repeat containing 3B, transcript variant X5
leucine-rich repeat-containing protein 3B
3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase isoform X1
peptide-N(4)-(N-acetyl-beta- glucosaminyl)asparagine amidase isoform X2
DNA topoisomerase II beta, transcript variant X3
DNA topoisomerase II beta, transcript variant X1
DNA topoisomerase II beta, transcript variant X2
retinoic acid receptor beta, transcript variant X1
retinoic acid receptor beta, transcript variant X2
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66% coverage of the annotated genomic feature by RNAseq alignments
thyroid hormone receptor beta, transcript variant X3
thyroid hormone receptor beta, transcript variant X2
thyroid hormone receptor beta, transcript variant X6
thyroid hormone receptor beta, transcript variant X1
thyroid hormone receptor beta, transcript variant X4
thyroid hormone receptor beta, transcript variant X5
thyroid hormone receptor beta, transcript variant X7
nuclear receptor subfamily 1 group D member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
NFKB inhibitor interacting Ras like 1, transcript variant X2
NFKB inhibitor interacting Ras like 1, transcript variant X1
NFKB inhibitor interacting Ras like 1, transcript variant X3
NF-kappa-B inhibitor-interacting Ras-like protein 1
basic salivary proline-rich protein 2-like
ubiquitin conjugating enzyme E2 E2, transcript variant X2
ubiquitin conjugating enzyme E2 E2, transcript variant X5
ubiquitin conjugating enzyme E2 E2, transcript variant X1
ubiquitin-conjugating enzyme E2 E2 isoform X2
ubiquitin-conjugating enzyme E2 E2 isoform X4
ubiquitin-conjugating enzyme E2 E2 isoform X1
ubiquitin conjugating enzyme E2 E2, transcript variant X4
ubiquitin conjugating enzyme E2 E2, transcript variant X3
ubiquitin-conjugating enzyme E2 E2 isoform X3
zinc finger protein 385D, transcript variant X1
zinc finger protein 385D, transcript variant X2
zinc finger protein 385D, transcript variant X4
zinc finger protein 385D, transcript variant X3
cytochrome c oxidase subunit 5B, mitochondrial
uncharacterized LOC122688122, transcript variant X1
uncharacterized LOC122688122, transcript variant X2
proline-rich protein HaeIII subfamily 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122687852, transcript variant X3
uncharacterized LOC122687852, transcript variant X4
uncharacterized LOC122687852, transcript variant X1
uncharacterized LOC122687852, transcript variant X2